Hillgene's GMP-grade K562 feeder cells have undergone systematic safety evaluations, including tumorigenicity and oncogenicity tests, all of which yielded negative results.
Combined with irradiation inactivation and a strict quality control system, this ensures the safe use of the product in cell therapy research and manufacturing.
Access detailed product information: Genetically Modified K562 Feeder Cell - Hillgene Biopharma Co., Ltd.
Contact Us for Product Validation Reports: Contact - Hillgene Biopharma Co., Ltd.
86 198 5711 6962 
info@hillgene.com 
English
